Share on StockTwits

Vascular Solutions Inc. (NASDAQ:VASC) issued an update on its first quarter earnings guidance on Tuesday morning. The company provided EPS guidance of $0.17-0.18 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.18, reports. The company issued revenue guidance of $29.5-30.5, compared to the consensus revenue estimate of $29.16 million.

On a related note, analysts at Feltl & Co. raised their price target on shares of Vascular Solutions from $21.00 to $23.00 in a research note to investors on Thursday, December 12th. They now have a buy rating on the stock.

Vascular Solutions Inc. (NASDAQ:VASC) traded up 2.13% on Tuesday, hitting $23.50. 83,934 shares of the company’s stock traded hands. Vascular Solutions Inc. has a 52-week low of $13.92 and a 52-week high of $24.85. The stock has a 50-day moving average of $23.10 and a 200-day moving average of $19.08. The company has a market cap of $395.6 million and a price-to-earnings ratio of 36.58.

Vascular Solutions (NASDAQ:VASC) last announced its earnings results on Tuesday, February 4th. The company reported $0.22 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.19 by $0.03. The company had revenue of $29.10 million for the quarter, compared to the consensus estimate of $28.61 million. During the same quarter in the prior year, the company posted $0.18 earnings per share. The company’s quarterly revenue was up 15.0% on a year-over-year basis. On average, analysts predict that Vascular Solutions Inc. will post $0.70 earnings per share for the current fiscal year.

Vascular Solutions, Inc (NASDAQ:VASC) is a medical device company focused on providing clinically advanced solutions to interventional cardiologists and interventional radiologists.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.